Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Bioorg Med Chem Lett ; 22(1): 149-53, 2012 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-22153344

RESUMEN

A series of novel phenylmethylene bis-isoxazolo[4,5-b]azepine derivatives (10) have been synthesized from 3-methyl-4-nitro-5-styrylisoxazoles 6. The reaction of 6 with 3,5-dimethyl-4-nitroisoxazole (7) in piperidine afforded the Michael type adducts 8, which on treatment with different substituted chalcones in the presence of piperidine gave the Michael adducts 9. Compounds 9 underwent reductive cyclization on treatment with SnCl(2)-MeOH to afford the title compounds 10. Structure of these compounds was established on the basis of IR, (1)H NMR, (13)C NMR and Mass spectral data. The title compounds 10a-j were evaluated for in vitro and in vivo anticancer activity. Compound 10j exhibited good anticancer activity as that of standard drug Cisplatin.


Asunto(s)
Antineoplásicos/farmacología , Azepinas/farmacología , Química Farmacéutica/métodos , Animales , Azepinas/química , Línea Celular Tumoral , Cisplatino/farmacología , Diseño de Fármacos , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Técnicas In Vitro , Concentración 50 Inhibidora , Isoxazoles/química , Espectroscopía de Resonancia Magnética/métodos , Espectrometría de Masas/métodos , Metanol/química , Ratones , Modelos Químicos , Neoplasias/tratamiento farmacológico , Espectrofotometría Infrarroja/métodos , Sales de Tetrazolio/farmacología , Tiazoles/farmacología
3.
Eur J Med Chem ; 55: 273-83, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22846796

RESUMEN

Novel series of 2-methyl-3-{3-methyl-5-[(E)-2-phenyl-1-ethenyl]-4-isoxazolyl}-3,4-dihydropyrimido[4,5-b]quinolin-4-ones 5 and 3-{3-methyl-5-[(E)-2-phenyl-1-ethenyl]-4-isoxazolyl}-3,4-dihydro-2H-chromeno[2,3-d]pyrimidin-4-ones 7 have been synthesized from isoxazolyl cyanoacetamide synthon 2. Compound 2 was obtained by reaction of 4-amino-3-methyl-5-styrylisoxazole 1 with ethyl cyanoacetate. Isoxazolyl pyrimido[4,5-b]quinolin-4-ones 5 were obtained from compounds 2 by condensation with o-nitro benzaldehyde followed by treatment with SnCl(2) and subsequent tandem N-acetylation and cyclodehydration with acetic anhydride. Compounds 2 were converted to isoxazolyl chromeno[2,3-d]pyrimidin-4-ones 7 by reaction with salicylaldehydes and subsequent cyclization with formaldehyde. Compounds 2-7 were characterized by IR, (1)H NMR, (13)C NMR, and Mass spectral data. The title compounds 5a-f and 7a-g were evaluated for their antimicrobial, anti-inflammatory and analgesic activity. Compounds 5d and 7e exhibited significant antimicrobial activity, potent anti-inflammatory and analgesic activities as that of standard drugs.


Asunto(s)
Diseño de Fármacos , Isoxazoles/química , Pirimidinonas/síntesis química , Pirimidinonas/farmacología , Quinolinas/síntesis química , Quinolinas/farmacología , Analgésicos/síntesis química , Analgésicos/química , Analgésicos/farmacología , Analgésicos/uso terapéutico , Animales , Antiinfecciosos/síntesis química , Antiinfecciosos/química , Antiinfecciosos/farmacología , Antiinfecciosos/uso terapéutico , Antiinflamatorios/síntesis química , Antiinflamatorios/química , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Bacterias/efectos de los fármacos , Conducta Animal/efectos de los fármacos , Técnicas de Química Sintética , Edema/tratamiento farmacológico , Hongos/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Pirimidinonas/química , Pirimidinonas/uso terapéutico , Quinolinas/química , Quinolinas/uso terapéutico , Ratas
4.
Eur J Med Chem ; 50: 344-9, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22385674

RESUMEN

A series of novel methylene bis-isoxazolo[4,5-b]azepines have been synthesized by reaction of 3,5-dimethyl-4-nitroisoxazole 6 with an appropriate methylene bis-chalcones 7 to obtain various Michael adducts 8a-i, which on treatment with SnCl(2)-MeOH underwent reductive cyclization to afford the title compounds 9a-i. Structure of these compounds were established on the basis of IR, (1)H NMR, (13)C NMR and mass spectral data. The title compounds 9a-i were evaluated for their in vitro antimicrobial and anticancer activities. Compounds 9h and 9i exhibited potent antimicrobial and anticancer activities as that of standard drugs.


Asunto(s)
Antibacterianos/síntesis química , Antibacterianos/farmacología , Antineoplásicos/síntesis química , Antineoplásicos/farmacología , Azepinas/síntesis química , Azepinas/farmacología , Bacterias/efectos de los fármacos , Neoplasias de la Mama/tratamiento farmacológico , Diseño de Fármacos , Isoxazoles/síntesis química , Isoxazoles/farmacología , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Femenino , Humanos , Riñón/citología , Riñón/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda